Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia.

Zhou K, Wahed AS, Cooper S, Di Bisceglie AM, Fontana RJ, Ghany MG, Khalili M, Lok AS, Perrillo R, Lee WM, Lau DTY, Sterling R, Janssen HLA, Terrault NA.

Am J Gastroenterol. 2019 Nov;114(11):1753-1763. doi: 10.14309/ajg.0000000000000400.

PMID:
31658127
2.

Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.

Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA; Hepatitis B Research Network.

Clin Gastroenterol Hepatol. 2019 Nov;17(12):2541-2551.e2. doi: 10.1016/j.cgh.2019.02.005. Epub 2019 Feb 8.

PMID:
30743006
3.

HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition.

Brouwer WP, Zhao Q, Hansen BE, Lau D, Khalili M, Terrault NA, Di Bisceglie AM, Perrillo RP, Fried MW, Wong D, Feld JJ, Belle SH, Janssen HLA; Hepatitis B Research Network.

Clin Gastroenterol Hepatol. 2019 Jan 7. pii: S1542-3565(19)30012-6. doi: 10.1016/j.cgh.2018.12.039. [Epub ahead of print]

PMID:
30630104
4.

Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.

Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS; Hepatitis B Research Network.

Hepatology. 2019 Jun;69(6):2338-2348. doi: 10.1002/hep.30417. Epub 2019 Mar 14.

PMID:
30549279
5.

Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop.

Block TM, Alter H, Brown N, Brownstein A, Brosgart C, Chang KM, Chen PJ, Cohen C, El-Serag H, Feld J, Gish R, Glenn J, Greten TF, Guo JT, Hoshida Y, Kowdley KV, Li W, Lok AS, McMahon B, Mehta A, Perrillo R, Rice CM, Rinaudo J, Schinazi RF, Shetty K.

Antiviral Res. 2018 Feb;150:93-100. doi: 10.1016/j.antiviral.2017.12.006. Epub 2017 Dec 14.

6.

A research agenda for curing chronic hepatitis B virus infection.

Alter H, Block T, Brown N, Brownstein A, Brosgart C, Chang KM, Chen PJ, Chisari FV, Cohen C, El-Serag H, Feld J, Gish R, Glenn J, Greten T, Guo H, Guo JT, Hoshida Y, Hu J, Kowdley KV, Li W, Liang J, Locarnini S, Lok AS, Mason W, McMahon B, Mehta A, Perrillo R, Revill P, Rice CM, Rinaudo J, Schinazi R, Seeger C, Shetty K, Tavis J, Zoulim F.

Hepatology. 2018 Mar;67(3):1127-1131. doi: 10.1002/hep.29509. Epub 2018 Jan 24. No abstract available.

7.

Hepatitis B virus reactivation during direct-acting antiviral treatment of chronic hepatitis C: A hidden danger of an otherwise major success story.

Perrillo RP.

Hepatology. 2017 Jul;66(1):4-6. doi: 10.1002/hep.29185. Epub 2017 May 18. No abstract available.

PMID:
28370190
8.

Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy.

Gonzalez SA, Perrillo RP.

Clin Infect Dis. 2016 Jun 1;62 Suppl 4:S306-13. doi: 10.1093/cid/ciw043. Review.

10.

Tumor necrosis factor inhibitor therapy for hepatitis B virus-infected individuals: How loud is the alarm bell?

Perrillo RP.

Hepatology. 2015 Jul;62(1):16-8. doi: 10.1002/hep.27806. Epub 2015 Apr 22. No abstract available.

PMID:
25808824
11.

Hepatitis B reactivation from immunosuppressive drug therapy: A global menace.

Perrillo RP.

Clin Liver Dis (Hoboken). 2015 Mar 27;5(2):39-42. doi: 10.1002/cld.448. eCollection 2015 Feb. No abstract available.

12.

Preventing hepatitis B reactivation due to immunosuppressive drug treatments.

Perrillo RP, Martin P, Lok AS.

JAMA. 2015 Apr 28;313(16):1617-8. doi: 10.1001/jama.2015.2571. No abstract available.

PMID:
25790287
13.

American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

Perrillo RP, Gish R, Falck-Ytter YT.

Gastroenterology. 2015 Jan;148(1):221-244.e3. doi: 10.1053/j.gastro.2014.10.038. Epub 2014 Oct 31. Review. No abstract available.

PMID:
25447852
14.

Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?

Di Bisceglie AM, Lok AS, Martin P, Terrault N, Perrillo RP, Hoofnagle JH.

Hepatology. 2015 Feb;61(2):703-11. doi: 10.1002/hep.27609. Review.

15.

Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver Diseases.

Hwang JP, Barbo AG, Perrillo RP.

J Viral Hepat. 2015 Mar;22(3):346-52. doi: 10.1111/jvh.12305. Epub 2014 Sep 15.

16.

Immunosuppression in Patients with Chronic Hepatitis B.

Seetharam A, Perrillo R, Gish R.

Curr Hepatol Rep. 2014 Jun 21;13:235-244. eCollection 2014. Review.

17.

Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.

Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS; Hepatitis B Research Network; Hepatitis B Research Network.

Clin Gastroenterol Hepatol. 2015 Jan;13(1):183-92. doi: 10.1016/j.cgh.2014.06.028. Epub 2014 Jul 8.

18.

Tratamiento del virus de la hepatitis B: ¿qué pacientes deben recibir tratamiento inmediato?

Perrillo RP.

Clin Liver Dis (Hoboken). 2014 Jan 13;2(Suppl 5):78-82. doi: 10.1002/cld.279. eCollection 2013 Nov. Review. Spanish. No abstract available.

PMID:
31333830
Free PMC Article
19.

Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.

Perrillo R, Buti M, Durand F, Charlton M, Gadano A, Cantisani G, Loong CC, Brown K, Hu W, Lopez-Talavera JC, Llamoso C.

Liver Transpl. 2013 Aug;19(8):887-95. doi: 10.1002/lt.23690.

20.

Hepatitis B virus treatment: Which patients require immediate treatment.

Perrillo RP.

Clin Liver Dis (Hoboken). 2013 Mar 1;2(1):11-14. doi: 10.1002/cld.140. eCollection 2013 Feb. Review. No abstract available.

21.

Internist diagnosis and management of chronic hepatitis B virus infection.

McMahon BJ, Block J, Haber B, London T, McHugh JA, Perrillo R, Neubauer R.

Am J Med. 2012 Nov;125(11):1063-7. doi: 10.1016/j.amjmed.2012.03.010.

PMID:
23098862
22.

Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: a review and recommendations for management.

Abramson A, Menter A, Perrillo R.

J Am Acad Dermatol. 2012 Dec;67(6):1349-61. doi: 10.1016/j.jaad.2012.04.036. Epub 2012 Jun 21. Review.

PMID:
22727462
23.

Reactivation of hepatitis B during immunosuppressive therapy: potentially fatal yet preventable.

Lok AS, Ward JW, Perrillo RP, McMahon BJ, Liang TJ.

Ann Intern Med. 2012 May 15;156(10):743-5. doi: 10.7326/0003-4819-156-10-201205150-00013. No abstract available.

24.

Reactivated hepatitis B due to medical interventions: the clinical spectrum expands.

Perrillo RP.

Antivir Ther. 2011;16(7):947-9. doi: 10.3851/IMP1877.

PMID:
22024509
25.

Editorial: Measurement of HBsAg concentration during antiviral therapy of hepatitis B: who, when, and why.

Perrillo R.

Am J Gastroenterol. 2011 Oct;106(10):1774-6. doi: 10.1038/ajg.2011.263.

PMID:
21979203
26.

Chronic hepatitis B infection: a workshop consensus statement and algorithm.

McHugh JA, Cullison S, Apuzzio J, Block JM, Cohen C, Leong SL, London WT, McNellis RJ, Neubauer RL, Perrillo R, Squires R, Tarrant D, McMahon BJ.

J Fam Pract. 2011 Sep;60(9):E1-8. Review.

PMID:
21901174
27.

Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance.

Perrillo RP, Hann HW, Schiff E, Mutimer D, Willems B, Leung N, Lee WM, Dixon S, Woessner M, Brosgart CL, Condreay LD, Gardner SD.

Hepatol Int. 2011 Jun;5(2):654-63. doi: 10.1007/s12072-010-9228-9. Epub 2011 Jan 5.

28.

Patient management and clinical decision making in HBV--aims of therapy and what we can achieve.

Perrillo R, Hou J, Papatheodoridis G, Manns M.

Antivir Ther. 2010;15 Suppl 3:45-51. doi: 10.3851/IMP1623. Review.

PMID:
21041903
29.

Entering the new era of therapy for HBV and HCV infections.

Peters MG, Perrillo RP, Jacobson IM, Ross DB, Doo EC, Murray JS, Wong JB.

J Fam Pract. 2010 Apr;59(4 Suppl):S51-8. No abstract available.

PMID:
20398591
30.

Withholding statins in patients with underlying liver disease: wise or unwise?

Perrillo RP.

Proc (Bayl Univ Med Cent). 2010 Apr;23(2):113-4. No abstract available.

31.

Effect of newer oral antiviral agents on future therapy of chronic hepatitis B.

Perrillo RP, Marcellin P.

Antivir Ther. 2010;15(1):13-22. doi: 10.3851/IMP1482. Review. Erratum in: Antivir Ther. 2010;15(5):801.

PMID:
20167987
32.

Benefits and risks of interferon therapy for hepatitis B.

Perrillo R.

Hepatology. 2009 May;49(5 Suppl):S103-11. doi: 10.1002/hep.22956.

PMID:
19399806
33.

Hepatitis B surface antigen quantification as a current-day paradox: obtaining the gold in the face of diminishing returns.

Perrillo RP.

Hepatology. 2009 Apr;49(4):1063-5. doi: 10.1002/hep.22932. No abstract available.

PMID:
19330864
35.

Impact of the hepatitis B virus genotype on pre- and post-liver transplantation outcomes.

Gaglio P, Singh S, Degertekin B, Ishitani M, Hussain M, Perrillo R, Lok AS; National Institutes of Health Hepatitis B Virus-Orthotopic Liver Transplantation Study Group.

Liver Transpl. 2008 Oct;14(10):1420-7. doi: 10.1002/lt.21563.

36.

Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B.

Sung JJ, Lai JY, Zeuzem S, Chow WC, Heathcote EJ, Perrillo RP, Brosgart CL, Woessner MA, Scott SA, Gray DF, Gardner SD.

J Hepatol. 2008 May;48(5):728-35. doi: 10.1016/j.jhep.2007.12.026. Epub 2008 Feb 29.

PMID:
18329126
37.

Hepatitis B: reflections on the current approach to antiviral therapy.

Zoulim F, Perrillo R.

J Hepatol. 2008;48 Suppl 1:S2-19. doi: 10.1016/j.jhep.2008.01.011. Epub 2008 Feb 4. Review.

38.

Customizing the management of chronic hepatitis B virus infection.

Gish RG, Perrillo RP, Jacobson IM.

Semin Liver Dis. 2007 Aug;27 Suppl 1:9-17. Review.

PMID:
17701845
39.

Halting the natural history of hepatitis B viral infection: a paradigm shift.

Perrillo RP, Jacobson IM.

Semin Liver Dis. 2007 Aug;27 Suppl 1:3-8. Review.

PMID:
17701844
40.

A pilot study of extended duration peginterferon alfa-2a for patients with hepatitis B e antigen-negative chronic hepatitis B.

Gish RG, Lau DT, Schmid P, Perrillo R.

Am J Gastroenterol. 2007 Dec;102(12):2718-23. Epub 2007 Jul 27.

PMID:
17662102
41.

Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens.

Anderson RD, Chinnakotla S, Guo L, Perrillo RP, Klintmalm GB, Davis GL.

Clin Transplant. 2007 Jul-Aug;21(4):510-7.

PMID:
17645711
42.

Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.

Wong SN, Reddy KR, Keeffe EB, Han SH, Gaglio PJ, Perrillo RP, Tran TT, Pruett TL, Lok AS.

Liver Transpl. 2007 Mar;13(3):334-42.

43.

Management of chronic hepatitis B virus infection: current perspectives for the nurse practitioner.

Perrillo R.

J Am Acad Nurse Pract. 2006 May;18(5):203-15. Review.

PMID:
16681707
44.

Hepatitis B virus replication x time equals trouble.

Perrillo R.

Gastroenterology. 2006 Mar;130(3):989-91. No abstract available.

PMID:
16530534
45.

Chronic hepatitis B: a critical appraisal of current approaches to therapy.

Perrillo RP, Gish RG, Peters M, Keeffe EB, Alberti A, Buti M, Cooksley WG, Fried MW, Hadziyannis SJ, Liaw YF, Naoumov NV, Schiff ER, Thio CL, Tsai N, Schalm S.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):233-48.

PMID:
16469685
46.

Therapy of hepatitis B -- viral suppression or eradication?

Perrillo RP.

Hepatology. 2006 Feb;43(2 Suppl 1):S182-93. Review.

PMID:
16447260
47.

Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy.

Terrault NA, Pawlotsky JM, McHutchison J, Anderson F, Krajden M, Gordon S, Zitron I, Perrillo R, Gish R, Holodniy M, Friesenhahn M.

J Viral Hepat. 2005 Sep;12(5):465-72.

PMID:
16108760
48.

Current treatment of chronic hepatitis B: benefits and limitations.

Perrillo RP.

Semin Liver Dis. 2005;25 Suppl 1:20-8. Review.

PMID:
16103978
49.

The use of HBsAg-positive organ donors: far more than meets the eye?

Perrillo RP, Eason JD.

Liver Transpl. 2005 Aug;11(8):875-7. Review. No abstract available.

50.

Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease.

Mason A, Theal J, Bain V, Adams E, Perrillo R.

Am J Gastroenterol. 2005 Apr;100(4):972-6.

PMID:
15784044

Supplemental Content

Loading ...
Support Center